Literature DB >> 12072207

A new translocation that rearranges the AML1 gene in a patient with T-cell acute lymphoblastic leukemia.

Fady M Mikhail1, Kadreya A Serry, Nadia Hatem, Zeinab I Mourad, Hala M Farawela, Dalal M El Kaffash, Lionel Coignet, Giuseppina Nucifora.   

Abstract

The AML1 gene (also known as RUNX1 or CBFA2), located in chromosome band 21q22, encodes a transcription factor which heterodimerizes with the CBFbeta protein forming a complex called human core binding factor (CBF). The CBF complex appears to regulate a number of genes important for hematopoiesis. AML1 is one of the most common targets of chromosomal rearrangements in human leukemias and has been involved in 14 chromosomal translocations to date. Here we report a new chromosomal translocation, t(4;21)(q31;q22) that disrupts the AML1 gene in a 12-year-old boy with newly diagnosed T-cell acute lymphoblastic leukemia (ALL). This is the first reported chromosomal translocation where AML1 is rearranged in childhood T-cell ALL. By metaphase fluorescence in situ hybridization analysis, the AML1 breakpoint was mapped using recombinant phage clones, and shown to be either immediately upstream or downstream of exon 5.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12072207     DOI: 10.1016/s0165-4608(01)00633-1

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  8 in total

1.  An unusual complex karyotype in myopericytoma.

Authors:  Aaron W James; Le Chang; Swati Shrestha; Carlos A Tirado; Sarah M Dry
Journal:  J Orthop       Date:  2015-01-29

2.  Runx1 deficiency predisposes mice to T-lymphoblastic lymphoma.

Authors:  Mondira Kundu; Sheila Compton; Lisa Garrett-Beal; Terryl Stacy; Matthew F Starost; Michael Eckhaus; Nancy A Speck; P Paul Liu
Journal:  Blood       Date:  2005-07-28       Impact factor: 22.113

3.  CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression.

Authors:  Christian Schürch; Carsten Riether; Matthias S Matter; Alexandar Tzankov; Adrian F Ochsenbein
Journal:  J Clin Invest       Date:  2012-01-09       Impact factor: 14.808

4.  The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin.

Authors:  Daniel Helbling; Beatrice U Mueller; Nikolai A Timchenko; Anne Hagemeijer; Martine Jotterand; Sandrine Meyer-Monard; Andrew Lister; Janet D Rowley; Barbara Huegli; Martin F Fey; Thomas Pabst
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

5.  Transcriptional regulation of the human MIP-1alpha promoter by RUNX1 and MOZ.

Authors:  Claire A P Bristow; Paul Shore
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

Review 6.  RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.

Authors:  Kentson Lam; Dong-Er Zhang
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

7.  SARS coronavirus 3b accessory protein modulates transcriptional activity of RUNX1b.

Authors:  Bhavna Varshney; Sudhakar Agnihothram; Sudhakar Agnihotram; Yee-Joo Tan; Ralph Baric; Sunil K Lal
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

8.  MYC rearrangement involving a novel non-immunoglobulin chromosomal locus in precursor B-cell acute lymphoblastic leukemia.

Authors:  Ja-Young Seo; Soo Hyun Lee; Hee-Jin Kim; Keon Hee Yoo; Hong Hoe Koo; Yong Gon Cho; Sam Im Choi; Sun-Hee Kim
Journal:  Ann Lab Med       Date:  2012-06-20       Impact factor: 3.464

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.